About
People and operating principles behind Obsevia
Obsevia builds AI workflows and consulting for SDS, labeling, and regulatory reviews — with named founders you can meet and verify.
We are a Berlin-based team building compliance AI and custom software for mid-market chemical, pharma, and medtech buyers. AI drafts and ranks; named reviewers keep disposition. Meet the founders below, or book a call.
Mission
Why we build
Automate the repetitive
Cut the hours spent on SDS diffs, questionnaire packs, and status chasing so specialists spend time on judgment calls.
Catch risk earlier
Surface missing languages, drifted classifications, and open findings before they delay a release or an audit.
Keep decisions owned
AI drafts and ranks; named reviewers approve, reject, or escalate with a trail you can show an inspector.
Platform
How the product works
See the full catalog on Products and comparison guides such as AI SDS review tools compared.
SDS & regulatory review
Intake, version diffs, completeness checks, and release queues in one workspace - not across inboxes and shared drives.
Cited compliance answers
Ask in plain language over controlled SDS and regulatory text. Answers come with sources your reviewers can verify.
Experts stay in control
Automation clears volume. Qualified people keep disposition. Lower cost without unsupervised publication.
Team
Who you work with
Engineering, go-to-market, and growth focused on regulated chemical and pharma buyers. Each person below is a schema.org Person with a stable profile URL for citations.
Julian Kleber
Cofounder & AI Engineering
Owns the AI and platform layer behind Obsevia's compliance workflows.
Kaja Szumilo
Cofounder & Marketing
Owns brand, messaging, and go-to-market for regulated buyers.
Rohan Pathak
Growth Manager
Runs outbound and pilot conversations with chemical and pharma teams.